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Abstract
We sought to determine whether oral contraception alters the gender-related
differences observed in the exercise pressor reflex during isometric handgrip
exercise. Fifteen men, fifteen normally menstruating women (WomenNM),
and fifteen women taking monophasic oral contraceptives (WomenOC) com-
pleted two trials of a 3-min isometric handgrip exercise protocol performed at
30% of their maximal voluntary contraction: (1) where arterial occlusion was
applied to the previously exercising arm during a 3-min recovery period
(Occlusion trial); (2) where no arterial occlusion was applied during recovery
(Control trial). Handgrip exercise elicited greater increases in mean arterial
pressure (MAP) in MEN compared to both female groups (P < 0.05), and in
WomenOC compared to WomenNM in both trials (P = 0.01, P = 0.03). After
3 min of recovery, sBP was 12% (P = 0.01) and 9% (P = 0.02) higher in the
Occlusion trial when compared to the Control trial for MEN and WomenOC.
Conversely, arterial occlusion in recovery from handgrip did not sustain ele-
vated sBP in the Occlusion trial, and sBP returned to recovery levels not dif-
ferent to the Control trial, in WomenNM (P = 0.41). These data indicate that
gender-related differences in the metaboreflex during isometric handgrip exer-
cise exist between men and normally menstruating women, but are blunted
when men are compared to women taking oral contraceptives. We conclude
that the suppression of 17b-estradiol and/or progestogen in women via the
administration of oral contraceptives attenuates sex-related differences in the
metaboreflex during isometric handgrip exercise.
Introduction
The cardiovascular responses to exercise are regulated by
a combination of efferent (central drive) and afferent
(neural inputs from contracting skeletal muscle, arterial
chemoreflexes, and baroreflexes) signals (Kaufman and
Forster 1996; Nobrega et al. 2014). The reflex mechanisms
originating in contracting skeletal muscles that adjust
blood pressure (whilst also modulating heart rate and
ventricular contractility) to meet the perfusive and meta-
bolic requirements of exercise are collectively termed the
exercise pressor reflex (EPR) (Nobrega et al. 2014). The
EPR consists of the mechanoreflex that is sensitive to
mechanical distortion, and the metaboreflex that is
responsive to a range of metabolic by-products produced
by contracting skeletal muscles (Seals et al. 1988; Rowell
and O’Leary 1990).
Men and women appear to rely on different physiologi-
cal mechanisms to maintain cardiovascular control
(Kneale et al. 2000; Reckelhoff 2001; Hart et al. 2009,
2011), and evidence suggests that the EPR is attenuated
in women when compared to men (Ettinger et al. 1996;
Jarvis et al. 2011). In a highly controlled study of men
and naturally cycling women, Jarvis et al. (2011) demon-
strated that women exhibited lower blood pressure (BP)
and muscle sympathetic nerve activity (MSNA) responses
compared to men during an isometric handgrip task per-
formed at 40% of maximal voluntary contraction (MVC).
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Interestingly, when the contribution of the mechanoreflex
was removed by ceasing handgrip, and arterial occlusion
was applied in recovery, the disparate BP responses
observed between men and women during handgrip
remained, thus revealing a gender-related difference in
the metaboreflex (Jarvis et al. 2011). Based on the find-
ings by Jarvis et al. (2011), and the previously reported
cardiovascular protective properties of 17b-estradiol
(Mendelsohn and Karas 1999; Dubey and Jackson 2001;
Rosano et al. 2007; Xue et al. 2009), it is reasonable to
suggest that estradiol might account, in part, for gender-
related differences in the metaboreflex. Indeed, the cycli-
cal fluctuation of female sex steroids across the menstrual
cycle have been shown to alter the sympathetic control of
circulation (Minson et al. 2000a,b; Charkoudian 2001).
Even so, Jarvis et al. (2011) reported that higher (mid-
luteal) versus lower (early follicular) circulating sex hor-
mone levels did not result in a further blunting of the BP
and MSNA responses to isometric handgrip observed in
women. These subsequent findings by Jarvis et al. (2011)
and others (Petrofsky et al. 1976) raise some doubt in the
notion that 17b-estradiol (i.e., endogenous estrogen) is
responsible for the gender-related difference observed in
the EPR. Nonetheless, circulating 17b-estradiol concentra-
tions remain elevated across the menstrual cycle when
compared to men. Thus, long-term exposure to
17b-estradiol may act to blunt any inter-phase difference
in EPR while causing the observed gender-related effect.
A comparison between normally menstruating women
and women taking oral contraceptives provides an appeal-
ing experimental model with which to examine the effects
of the long-term suppression of 17b-estradiol and/or the
long-term administration of ethinyl-estradiol (i.e., syn-
thetic estrogen delivered in the oral contraceptive pill) on
the EPR. A comparison of the EPR among men, normally
menstruating women, and women taking oral contracep-
tives would provide information regarding the gender-
related difference in the EPR as well as insight into the
unique effects of 17b-estradiol compared to exogenous
estrogen (i.e., ethinyl-estradiol) on cardiovascular physiol-
ogy. In this study, we examined the BP and heart rate
(HR) responses during isometric handgrip exercise with
and without the application of arterial occlusion during
recovery in both men and women. We hypothesized that
the EPR response would be attenuated in normally men-
struating women when compared to men. Furthermore,
while the existing evidence is too scarce to formulate an
evidence-based hypothesis surrounding the effect of oral
contraceptives on the EPR, it was tentatively predicted
that the women taking oral contraceptives would have a
similar BP and HR response to men due to the suppres-
sion of endogenous estrogen.
Materials and Methods
Ethical approval
The Griffith University Human Research Ethics Commit-
tee approved all procedures, and all participants provided
written informed consent before commencing the study.
Subjects
Fifteen men (MEN), fifteen normally menstruating
women (WomenNM), and fifteen women who were tak-
ing oral contraceptives (WomenOC) volunteered to par-
ticipate as subjects in this study. All subjects were
recreationally active (moderate-intensity, endurance-type
exercise 3–5 days/week for 30 min), nonsmokers, and did
not have any documented history or clinical signs or
symptoms of pulmonary, cardiovascular, or metabolic
disorders. All WomenNM reported regular menstrual
cycles (i.e., occurring on a 28 to 30-days cycle) and had
not taken any form of synthetic estrogen or progesterone
for at least 6 months prior to the study. The WomenOC
were using a combined monophasic oral contraceptive pill
for at least 12 months (range 12–72 months) prior to the
beginning of the study and continued their oral contra-
ceptive pill throughout the experimental period. All sub-
jects had never knowingly been pregnant.
Experimental design
Subjects visited the laboratory on two separate occasions.
The first visit was used to obtain written, informed con-
sent, undertake preliminary health screening, and famil-
iarize the subjects with the experimental procedures and
equipment. All subjects were asked to complete a detailed
medical history questionnaire that highlighted any illness
or any other factor that may have prevented participation
in the study. The investigator then explained all testing
procedures and all related risks and benefits associated
with the experiment before subjects were familiarized with
the testing procedures and equipment.
During familiarization, subjects performed a maximal
isometric voluntary contraction (MVC) using a hand
dynamometer (Jamar, Sammons Preston, Bolingbrook,
Illinois, USA). The grip span on the dynamometer lever
was adjusted individually so that a comfortable grip was
achieved. Subjects were instructed to squeeze the lever
and exert maximal force for 3 sec with their right hand.
Each subject was allowed three attempts and the highest
of these were recorded as their MVC. Thirty percent of
the MVC (30%MVC) was calculated and used as the
workload for the experimental exercise protocol.
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Subjects performed two, 3-min bouts of isometric
handgrip exercise during the second laboratory visit.
Blood samples were collected before the start of the
experiment during the early follicular phase of the men-
strual cycle for WomenNM (i.e., day 2–6 of the menstrual
cycle), and during the withdrawal phase for WomenOC
(i.e., day 2–6 of placebo pill ingestion) for the subsequent
analysis of serum 17b-estradiol and progesterone concen-
tration (Sullivan Nicolaides Pathology, Australia). MEN
were tested at no specific time of the month. All exercise
tests were conducted in the morning at least 2 h post-
prandial. Participants were instructed not to perform
intense physical exercise or consume caffeine or alcoholic
beverages for 24 h prior to each exercise test. All experi-
mental testing was conducted in a climate controlled
room to maintain temperature (24  1°) and humidity
(55  2%).
Isometric handgrip exercise protocol
The handgrip protocol consisted of two trials, both
including 10 min of baseline rest, 3 min of isometric
handgrip exercise, 3 min of recovery, and 5 min of rest.
Each subject sat upright in a chair; the height of the chair
was adjusted so that the shoulder was completely relaxed
with no depression or elevation and there was 0° abduc-
tion of the upper arm. During handgrip exercise, the
elbow joint was flexed at 90° and the forearm was sup-
ported on the table immediately in front in the anatomical
position. During baseline, recovery, and resting measure-
ments, subjects pronated their forearm to have their hand
lie flat on the table facing palm down and relaxed.
After the 10 min baseline period, subjects were
instructed to squeeze the lever of the handgrip
dynamometer until the needle on the dial reached the
predetermined load of 30%MVC. Visual feedback to
the subjects and the investigators from the dial on the
dynamometer ensured that 30%MVC was maintained for
the full 3 min of the exercise period. Subjects were
instructed to remain still during the 3-min recovery and
5-min rest periods and to leave their arm in the pronated
position with their hand flat on the table. For one trial,
arterial occlusion was applied to the previously exercising
arm during the recovery period (i.e., Occlusion trial)
whereas during the second trial, subjects returned their
hand to the pronated position without arterial occlusion
(i.e., Control trial). During the Occlusion trial, a sphyg-
momanometer cuff was placed on the upper (exercising)
arm and inflated to a pressure of 230 mmHg immediately
prior to the cessation of isometric handgrip exercise to
obstruct blood flow during the entire 3-min recovery per-
iod. The Control trial was identical to the Occlusion trial
with the exception that the cuff was not inflated during
the recovery period. The order of the two trials was ran-
domized and separated by 25 min.
A CM5 electrode configuration with a Lohmeier elec-
trocardiograph (M607, Munchen, Germany) was used to
monitor cardiac rhythm and measure HR. Heart rate was
recorded every minute during baseline (10 min) and at
15-sec intervals during handgrip exercise (3 min), recov-
ery (3 min), and rest (5 min). Averaged HR data from
the final minute of each stage (baseline, exercise, recovery,
and rest) are reported in the Results. A mercury sphyg-
momanometer (Standby model, W. A. Baumanometer Co
Inc., Copiague, NY, USA) was used to measure BP. The
sphygmomanometer cuff was placed on the subject’s
nonexercising (left) arm, at the level of the heart, and
taped securely. A stethoscope was placed over the antecu-
bital fossa and the cuff was inflated to ~180 mmHg. Sys-
tolic BP (sBP) was recorded at the onset of the first
Korotkoff sound while diastolic BP (dBP) was recorded at
the fourth Korotkoff sound. Blood pressure was deter-
mined by a trained Exercise Scientist with at least 3 yr
experience in the measurement of blood pressure, and BP
results are reported for the final minute of each stage.
Statistical analyses
Subject characteristics were compared across the three
groups using one-way ANOVA. Fully factorial two-way
ANOVA with repeated measures for time was used to
examine differences across trial (Control and Occlusion)
and separately across group (MEN, WomenNM, and
Women OC) for BP and HR. Pairwise comparisons with
Bonferroni corrections were performed where a significant
F value existed. Significance was accepted at P < 0.05. All
data are presented as mean  standard deviation (for




Subject characteristics are displayed in Table 1. MEN
were significantly older than both groups of women
(P < 0.01), but there was no difference in age between
WomenNM and WomenOC (P = 0.47). Although
WomenNM and WomenOC were of similar height
(P = 0.29) and body mass (P = 0.06), MEN were taller
(P < 0.01) and heavier (P < 0.01) than both the female
groups. While there was no difference in progesterone
concentrations between groups (P > 0.05), MEN had sig-
nificantly lower plasma estradiol concentrations when
compared to WomenNM but significantly higher plasma
estradiol concentrations than WomenOC (P < 0.05).
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Similarly, WomenOC had significantly lower plasma
estradiol concentrations than WomenNM (P < 0.05).
MEN demonstrated a higher MVC for handgrip
(58  2 kg) than both female groups (P < 0.01), yet
WomenNM (39  2 kg) and WomenOC (39  1 kg)
demonstrated a similar MVC (P = 0.79). The 30% MVC
loads used by the MEN, WomenNM, and WomenOC
were 17  0.7, 12  0.5, and 12  0.4 kg, respectively.
Heart rate response during the isometric
handgrip exercise protocol
Figure 1 presents the changes in HR measured before,
during, and after isometric handgrip exercise in MEN,
WomenNM, and WomenOC. Heart rate measured during
baseline (HRBL) was not different among the three subject
groups for either trial (P > 0.05) or between the Occlu-
sion and Control trials for any of the groups (P > 0.05).
Heart rate increased from baseline in MEN (Control trial
= P < 0.01; Occlusion Trial P < 0.01), WomenNM
(P < 0.01, P < 0.01), and WomenOC (P < 0.01,
P < 0.01) after 3 min of 30%MVC handgrip exercise in
both trials. The increase in HR during handgrip exercise
(HREX) was similar for both trials in all groups
(P > 0.05), but was greater in magnitude in MEN com-
pared to both female groups (P < 0.05). Heart rate dur-
ing recovery (HRREC) was decreased from HREX in all
groups during both trials (P < 0.01), returning to values
that were not significantly different from baseline and
remaining stable during the 5 min of rest (i.e., HRREST)
when no occlusion was applied in either trial (P > 0.05).
Blood pressure response during the
isometric handgrip exercise protocol
Figure 2 illustrates the changes in sBP and dBP measured
during the Occlusion and Control trials of isometric
handgrip exercise. Baseline systolic (sBPBL) and diastolic







Age (year) 25  31 21  2 21  2
Height (cm) 180  91 169  7 166  7
Body mass (kg) 75.9  10.61 65.7  8.5 60.5  5.5
Systolic BP (mmHg) 121  91 112  6 110  9
Diastolic BP (mmHg) 75  101 64  7 68  8
Plasma estradiol (pmolL1) 97.3  23.01 132.3  41.7 45.9  22.82
Plasma Progesterone (pmolL1) 0.58  0.12 0.78  0.33 0.59  0.11
Values represent mean  standard deviation. MVC, Maximal voluntary contraction performed isometrically on a hand dynamometer with the
right hand.
1
Significantly different to both female groups.
2
Significantly different to WomenNM; P ≤ 0.05.
Figure 1. Heart rate measured in MEN, normally menstruating women (WomenNM) and women using oral contraception (WomenOC) at
baseline (BL) and after 3 min (Ex) of isometric handgrip exercise performed at 30%MVC. Blood pressure was also measured after 3 min of
recovery (REC) with (i.e., Occlusion trial = open markers) and without (Control trial = closed markers) arterial occlusion applied as well as after
5 min of rest (Rest) immediately following Rec without occlusion in both trials. (A) significantly different from previous time-point within group
and trial; (B) significantly different between from Control within group and time-point; (C) significantly different from both female groups
within trial and time-point; (D) significantly different from WomenNM within trial and time-point. Statistical significance accepted at P ≤ 0.05.
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(dBPBL) blood pressure were not different between the
Control and Occlusion trials (P > 0.05), but were higher
in men compared to women in both trials (P < 0.05).
There were no differences in sBPBL or dBPBL between
WomenNM and WomenOC in either trial (P > 0.05).
sBP and dBP increased from baseline during handgrip
exercise in all groups (P < 0.05). However, dBPEX reached
98  15 and 97  9 mmHg in MEN during the Control
and Occlusion trials, respectively; values that were higher
(P < 0.05) than that recorded for WomenNM (Control
trial: 76  8; Occlusion trial: 74  8 mmHg) and
WomenOC (Control trial: 82  7; Occlusion trial:
84  11 mmHg). Furthermore, dBPEX was higher in
WomenOC compared to WomenNM in both the Control
(P = 0.05) and Occlusion (P = 0.01) trials. Similarly,
sBPEX reached 152  19 and 151  18 mmHg in MEN
during the Control and Occlusion trials, respectively, and
were higher (P < 0.05) than the sBPEX values for
WomenNM (Control trial: 120  11; Occlusion trial:
120  13 mmHg) and WomenOC (Control trial:
135  18; Occlusion trial: 135  16 mmHg). sBPEX was
higher in WomenOC compared to WomenNM in both
the Control (P = 0.01) and Occlusion (P = 0.03) trials.
After 3 min of recovery in the Control trial, dBP
returned to values not different from dBPBL in all groups
(P > 0.05), whereas sBP returned to values not different
from sBPBL in WomenNM (P = 0.69) and WomenOC
(P = 0.62), but were still elevated in men (P = 0.02).
After 3 min of recovery in the Occlusion trial, dBPREC
was ~14% higher in both MEN (P = 0.01) and Wome-
nOC (P = 0.01) when compared to dBPREC recorded in
the Control trial. In contrast, there was no difference in
the dBPREC measured in the Occlusion compared to the
Control trial for WomenNM (P = 0.57). Similarly,
sBPREC measured in the Occlusion trial were 12%
(P = 0.01) and 9% (P = 0.02) higher for MEN and
WomenOC when compared to the sBPREC recoded in the
Control trial. However, arterial occlusion in recovery did
not alter the sBP response for WomenNM where sBPREC
was not different between the Occlusion and the Control
trials (P = 0.41). sBP and dBP returned to values not dif-
ferent between trials or from baseline values in MEN
(Control trial, P = 0.17; Occlusion trial, P = 0.66) and
WomenOC (Control trial, P = 0.82; Occlusion trial,
P = 0.54) after 5 min of rest with no arterial occlusion in
both trials.
Discussion
We demonstrate here that, like men, BP measured in
women taking oral contraception remains elevated above
baseline when arterial occlusion is applied in recovery
Figure 2. Systolic (upper plots) and diastolic (lower plots) blood pressure measured in MEN, normally menstruating women (WomenNM), and
women using oral contraception (WomenOC) at baseline (BL) and after 3 min (Ex) of isometric handgrip exercise performed at 30%MVC.
Blood pressure was also measured after 3 min of recovery (Rec) with (i.e., Occlusion trial = open markers) and without (Control trial = closed
markers) arterial occlusion applied, as well as after 5 min of rest (Rest) immediately following Rec without occlusion in both trials. (A)
significantly different from previous time-point within group and trial; (B) significantly different from Control within group and time-point; (C)
significantly different from both female groups within trial and time-point; (D) significantly different from WomenNM within trial and time-
point. Statistical significance accepted at P ≤ 0.05.
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from handgrip exercise. This finding contrast that
observed in normally menstruating women, where BP
returns to baseline following isometric exercise despite
arterial occlusion. In contrast, the heart rate responses
across time and between experimental conditions were
similar in men, normally menstruating women, and
women taking oral contraception. This study provides
evidence to suggest that oral contraceptive use attenuates
the gender-related differences observed in the EPR during
isometric handgrip exercise, which has implications for
the design of studies investigating the EPR utilizing
female subjects.
Previous studies investigating the influence of gender
on sympathetic nerve responses have reported higher peak
HR as well as higher SBP and DBP values during isometric
handgrip exercise in men compared to women (Ettinger
et al. 1996; Wong et al. 2007; Jarvis et al. 2011). These
findings may be explained, in part, by the greater work
performed during 3 min of isometric handgrip exercise in
men compared to women (MEN = 22.9  3.5;
WomenNM = 18.1  2.5 kg/kg body mass; P < 0.01),
resulting in a greater activation of central command and/
or afferent factors such as the EPR. In an attempt to con-
trol for the unequal “tension generated” between men and
women, Ettinger et al. (1996) compared the muscle sym-
pathetic nerve activity (MSNA) in men and women
matched for MVC during thumb adduction exercise per-
formed at 60%MVC. These authors reported greater
MSNA in men compared to women, and suggested that
the gender-related differences in the sympathetic response
to isometric exercise are independent of the inherent gen-
der differences in active muscle mass. While we cannot
rule out that the greater “total work” performed by men
compared to women is responsible for the greater increase
in BP and HR during exercise, the varying profile of the
BP response during recovery from isometric handgrip
exercise between MEN and WomenNM during the Occlu-
sion trial suggests that the BP response may not simply be
linearly related to work performed, particularly with
respect to the contribution/influence of the metaboreflex.
Several authors have hypothesized that circulating
17b-estradiol may be responsible for the gender-related
differences in BP responses to isometric exercise. Animal
studies demonstrate that higher levels of estradiol are
associated with enhanced lipid oxidation during exercise
(Hatta et al. 1988; Kendrick and Ellis 1991; Ellis et al.
1994), minimising the interstitial concentrations of meta-
bolic by-products responsible for activating the metabore-
flex (e.g., hydrogen ions, adenosine, and potassium).
Alternatively, it has been suggested that 17b-estradiol
could increase blood flow to the muscle via endothelium-
dependent flow mediated dilation as a result of enhanced
nitric oxide activity (Lieberman et al. 1994; Hernandez
et al. 2000; Khalil 2005). Improved blood flow could also
reduce the activation of the metaboreflex by enhancing
the washout of interstitial metabolic by-products. Further-
more, an increase in the availability of nitric oxide as a
result of high levels of circulating estradiol may increase
b-adrenergic-mediated vasodilatation in the peripheral
vasculature (Hart et al. 2011). By examining the BP
responses in recovery from isometric handgrip exercise
with arterial occlusion, we were able to isolate the meta-
boreflex from the mechanoreflex. BP measured during
recovery from handgrip exercise during the Occlusion
trial in this study was elevated above baseline in MEN,
but not WomenNM, which is suggestive of a blunted
metaboreflex in WomenNM. Our results support the
findings of Ettinger et al. (1996) who found a reduced
MSNA response in women during ischemic recovery from
handgrip exercise compared to men, and lend support to
the notion that chronically elevated 17b-estradiol may
play a role in reducing the activation of the metaboreflex
during isometric exercise.
In order to further examine the proposed effects of
17b-estradiol on the cardiovascular response to isometric
exercise, we compared HR and BP values during and after
isometric handgrip exercise between WomenNM and
WomenOC. WomenOC demonstrated a greater increase
in both sBP and dBP after 3 min of isometric handgrip
exercise when compared to WomenNM. Given the two
groups were matched for age, training status, and grip
strength, and that the same total work was performed dur-
ing the isometric handgrip exercise, it is unlikely that the
greater increase in BP recorded during exercise for Wome-
nOC was due to a greater activation of central command.
Alternatively, we propose that the greater increase in BP
measured during exercise in WomenOC compared to
WomenNM was due to a greater activation of the meta-
boreflex. Indeed, sBP and dBP remained elevated above
baseline values during recovery from isometric handgrip
exercise during the Occlusion trial in WomenOC, but
returned to values not statistically different from baseline
in WomenNM. This suggests that, in contrast to
WomenNM, the metaboreflex in WomenOC may be oper-
ating in a functionally similar pattern to MEN.
We demonstrated evidence of an attenuated metabore-
flex in WomenNM during the follicular phase of the
menstrual cycle when circulating concentrations of
17b-estradiol are low. These findings, in agreement with
Jarvis et al. (2011), suggest that acute variations at the
concentrations of circulating 17b-estradiol may not di-
rectly influence the metaboreflex. Rather, the long-term
suppression of 17b-estradiol via the administration of oral
contraceptives may result in alterations in genomic mech-
anisms responsible for gene and protein expression (Fis-
cher et al. 2002; Kuhl 2005), that, in turn, influence the
2018 | Vol. 6 | Iss. 5 | e13629
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metaboreflex. Furthermore, research is warranted to
explore the notion that long-term suppression of
17b-estradiol results in genomic alterations that may
affect endothelium-dependent vasodilation.
We cannot discount the effect of progesterone on the
gender-related differences in the EPR nor its effect on the
EPR-related differences observed between WomenNM
and WomenOC. While no previous study has reported
the independent effect of progestogen or progestin on the
EPR, previous research demonstrates that progesterones
influence cardiovascular regulation (Heesch and Rogers
1995; Brunt et al. 2013). For example, Brunt et al. (2013)
report that endogenous progesterone (i.e., progestogen)
blunts carotid vasomotor baroreflex sensitivity, while
others show that progestogen modulates neurotransmitter
release in medullary regions involved in autonomic regu-
lation (Heesch and Rogers 1995). Therefore, further
research is warranted to elucidate the independent effects
of 17b-estradiol/progestogen and ethinyl-estradiol/proges-
tin on the metaboreflex during isometric exercise. An
additional limitation of this study is that, although all
WomenOC in this study were taking a combined
monophasic oral contraceptive pill, the exact type and
dosage was not specified. It is possible that varying doses
and types of progestins contained in monophasic oral
contraceptive pills may have influenced its effect on the
EPR (Africander et al. 2011). It is also possible that the
subjects’ pre-exercise food consumption may have exerted
a small influence on the measured variables, and thus,
future studies should test participants in a fasted state.
Furthermore, given a fixed-duration protocol was adopted
in order to directly compare the cardiovascular responses
between groups at each time point, we cannot conclude
what outcomes could have occurred had a test to fatigue
been utilized. Finally, in order to provide a complete pic-
ture of the influence of OC on the metaboreflex, cardio-
vascular responses to isometric handgrip exercise with
and without occlusion should be examined at various
stages throughout the menstrual cycle and also across dif-
ferent forms of OC (i.e., biphasic, triphasic, progesterone
only). Thus, future research should prioritize such investi-
gations. Nevertheless, the current research provides
important and novel insight into the effect of oral contra-
ceptives on the EPR.
This study examined whether muscle metaboreflex con-
trol of BP and HR is influenced by differences in circulat-
ing estrogen and progesterone among men, normally
menstruating women, and women taking the oral contra-
ceptive pill. Interestingly, the increase in HR observed
during isometric handgrip was not different between
WomenNM and WomenOC, and the exercise-induced
increase in HR was not maintained in recovery from
handgrip during the Occlusion trial in any group. This
suggests that the metaboreflex does not act to adjust HR
during isometric exercise. In contrast, we demonstrated
that gender-related differences in the metaboreflex control
of BP during handgrip exercise exist between men and
normally menstruating women, but are blunted when
men are compared to women using oral contraception.
We conclude that the suppression of 17b-estradiol and/or
progestogen in women via the administration of oral con-
traceptives attenuates sex-related differences in the meta-
boreflex during isometric handgrip exercise.
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